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was induced in all rabbits by intermittent high-cholesterol diet and
endothelial denudation. From the ninth week, the rabbits in group P
received pioglitazone (10 mg$kg-1$d-1) in addition to the diet, till the
end of experiment. PET/CT scans were performed at 8 week and 18
week in all survival rabbits, to obtain FDG uptake parameters (mean
standardized uptake value, SUVmean and maximal standardized up-
take value, SUVmax). Concomitantly, serum samples were obtained
for analysis of blood glucose (G), triglycerides (TG), total cholesterol
(Ch), HDL, LDL, hs-CRP and MMP-9. All survival rabbits underwent 2
pharmacological triggerings to induce plaque rupture at 18 week. Af-
ter pharmacological triggering, all rabbits were euthanatized, aortic
histopathological analysis were performed.
CONCLUSIONS Pioglitazone can decrease the incidence of thrombotic
events and attenuate plaque vulnerability by ways of modulating
vascular inﬂammation, decreasing plaque area and neovessels. 18F
FDG PET/CT, seems capable of monitoring inﬂammation in asses anti-
atherosclerotic effect of pioglitazone.
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OBJECTIVES Previous studies have indicated that immune-inﬂam-
matory activation plays an important role in the development of
myocardial remodeling in patients with chronic heart failure. Cardiac
ﬁbroblast (CFb) plays a central role in the pathogenesis of myocardial
ﬁbrosis. Triptolide (TPL), PG-490, is a diterpene triepoxide with
potent immunosuppressive and anti-inﬂammatory properties and has
been used in China for centuries to treat immune-related disorders.
However, the effects of TPL on myocardial ﬁbrosis remain unclear.
The objective of this study was to determine whether TPL can protect
myocardial ﬁbrosis by inhibiting the proliferation of CFbs.
METHODS Myocardial tissue in newborn rats was digested with low
concentration trypsin and collagenase. The CFbs and myocardial cells
were isolated with differential adherence method. Angiotensin II (10-7
mol/L) was used to promote the proliferation of CFbs. TPL (100 ng/ml)
was applied for 48 hours to inhibit CFbs proliferation. MTT assay was
used to detect cell survival rate in vitro. Flow cytometry was per-
formed to analyze apoptosis. Collagen concentration was measured
using the hydroxyproline assay kit. Quantitative real-time PCR was
used to detect the expression of TGF-b1 and Smad3.
RESULTS Compared to the control group, CFbs in the angiotensin II
treated group proliferated signiﬁcantly. However, compared to the
angiotensin II treated group, the cell survival rate (324.64157.95%
vs.123.3834.32%, P<0.01) and collagen concentration (10.674.03
mg/ml vs. 4.401.49 mg/ml, P¼0.01) in TPL treated group were
signiﬁcantly lower. TPL treatment also promoted apoptosis in angio-
tensin II treated CFbs. The apoptosis rates of the angiotensin II and
TPL treated groups were 0.920.61% and 4.320.43%, respectively.
Furthermore, compared against the angiotensin II treated group, TPL
treatment down-regulated the expression of TGF-b1 (1.361.22 vs.
0.660.15, P<0.01) and Smad3 (1.530.14 vs. 0.250.10, P<0.05)
mRNA levels signiﬁcantly in rat CFbs in vitro.
CONCLUSIONS Our ﬁndings indicate that TPL may inhibit angio-
tensin II induced cardiac ﬁbroblast proliferation by down-regulating
the TGF-b1/Smad3 signaling pathway. TPL may be a potential thera-
peutic drug for myocardial ﬁbrosis.
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OBJECTIVES L-carnitine is a carrier in the course of the fatty acids
Metabolism. The fatty acids Metabolic Processes is damaged when
myocardial ischemia. The aim of this study is to determine the effectsof L-carnitine with different dosage on left ventricular function and
hemodynamics in AMI rats.
METHODS AMI were conducted by ligating left anterior descending
branch in male SD rats. Rats were randomly assigned to one of the
following groups: AMI control group(n¼12), large dosage L-carnitine
group (120mg100g-1d-1, n¼12), middle dosage L-carnitine group
(60mg100g-1d-1, n¼13), small dosage L-carnitine group(30mg100g-
1d-1, n¼11). Sham operated rats(n¼10) were selected randomly as
non-infarction control group. L-carnitine was administered by direct
abdominal cavity’s injection for four weeks. Then echocardiography
examination and hemodynamic studies were performed.
RESULTS
1. Compared with the AMI groups, a signiﬁcant increase could be seen
in ejection fraction(EF, 68.085.98%, 68.205.52% ,65.3512.07%
respectively) and fractional shortening (FS, 33.474.24%,
34.524.19%, 31.387.60% respectively) among in small, middle and
large dosage L-carnitine groups(all P<0.01), and a signiﬁcant decrease
could be seen in left ventricular end-diastolic volume(LVEDV,
0.580.13ml, 0.630.27ml, 0.650.20ml respectively) and left ven-
tricular end- systolic volume(LVESV, 0.170.08ml, 0.200.12ml,
0.210.11ml respectively) in small, middle and large dosage L-carni-
tine groups, no signiﬁcant difference among the three L-carnitine
groups(P>0.05).
2. Compared with the AMI group, a signiﬁcant decrease could be seen
in left ventricular end-diastolic pressure (LVEDP, 0.929.06mmHg,
2.724.32mmHg, 2.997.45mmHg respectively)(all P<0.01), and
a signiﬁcant increase could be seen in left ventricular pres-
sure maximal rate of rise (þdp/dt, 4646.02650.26mmHg/s,
4821.39956.18mmHg/s, 4544.87617.77mmHg/s respectively)
(P<0.05), left ventricular pressure maximal rate of fall(-dp/dtmax,
4358.25700.65mmHg/s, 4360.79754.10mmHg/s, 4409.26
929.50mmHg/s respectively), and left ventricular systolic pressur-
e(LVSP, 84.856.22mmHg, 85.177.22mmHg, 87.4212.31 mmHg
respectively), no signiﬁcant difference in these indexes among the
small, middle and large dosage L-carnitine groups, and no signiﬁcant
difference in aortic systolic blood pressure( ASBP), aortic diastolic
blood pressure(ADBP), mean aortic pressure(MAP) and heart rate (HR)
among the three L-carnitine groups.
CONCLUSIONS Early treatment with L-carnitine in three dosages
could improve hemodynamic state and left ventricular function
effectively in AMI rats.
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OBJECTIVES To ﬁnd the best method of cardiac stem cell (CSC)
isolation and culture through comparing the effect of different
methods in laying cell adhesion agent and different serum concen-
trations in culture.
METHODS Experiment was conducted with healthy newborn wistar
rats (one day of birth). The heart tissues were digested with trypsin
and collagenase repeatedly after it was removed from the rat chest
under sterile conditions, then the digested tissues were cultured in
cell culture bottle laying with ﬁbronectin (FN). The ﬁrst passage cells
were cultured in the bottle laying with Poly -D- lysine (PDL). Compare
of the CSC numbers and proliferation was conducted among different
cell groups, which were the group cultured in bottles laying at 37 C
with the other one laying at room temperature, and the group
cultured by modiﬁed cardiosphere growing medium (CGM)(pre-
scription is IMDM, 11% fetal bovine serum, 1% penicillin and strep-
tomycin, 1% L- glutamic acid) with the other one by normal CGM
(prescription is IMDM, 10% fetal bovine serum, 1% penicillin and
streptomycin, 1% L- glutamic acid). The CSCs were identiﬁed by
immunohistochemistry.
RESULTS CSCs were isolated from myocardial tissue of neonatal rats
successfully, C-kit positive. FN and PDL coating at 37C can signiﬁ-
cantly promote cell adhesion, increase cell growth rate and reduce the
cell doubling time (p<0.05) comparing with that at room temperature.
Application of modiﬁed CGM may accelerate cell growth speed and
reduce the cell doubling time (p<0.05).
